Marvin L. White - 29 Jan 2023 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: President and CEO, Director
Signature: /s/ SoYoung Kwon, attorney-in-fact
Issuer symbol: APVO
Transactions as of: 29 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 30 Jan 2023, 12:07:53 UTC
Previous filing: 07 Jun 2022
Next filing: 07 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+4,791	+19%		30,555	29 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-4,791	-50%	$0.000000	4,792	29 Jan 2023	Common Stock	4,791		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On January 29, 2021, the reporting person was granted 14,375 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022.